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Hyperbaric Oxygen Attenuates Apoptosis and
Decreases Inflammation in an Ischemic Wound
Model
Qixu Zhang1, Qing Chang1, Robert A. Cox2, Xuemei Gong1 and Lisa J. Gould1
The molecular mechanisms whereby hyperbaric oxygen (HBO) improves ischemic wound healing remain
elusive. In this study, a rat model of wound ischemia was used to test the hypothesis that HBO enhances wound
healing by modulating hypoxia-inducible factor-1a (HIF-1a) signaling. Male Sprague–Dawley rats underwent
creation of a previously validated ischemic flap. Three groups underwent daily treatment: HBO (90minutes,
2.4 atm); systemic administration of the free radical scavenger, N-acetylcysteine (NAC 150mgkg1 intraper-
itoneal); control (neither HBO nor NAC). HBO treatment improved healing of the ischemic wounds. Analysis of
ischemic wound tissue extracts demonstrated significantly reduced expression of HIF-1a, p53, and BNip3.
Additionally, HBO increased expression of Bcl-2 while decreasing cleaved caspase-3. DNA fragmentation was
abolished and the number of TUNEL-positive cells was reduced compared to the other groups. Vascular
endothelial growth factor, cyclooxygenase-2, and neutrophil infiltration were reduced in ischemic wounds
treated with HBO. These results indicate that HBO improves ischemic wound healing by downregulation of
HIF-1a and subsequent target gene expression with attenuation of cell apoptosis and reduction of inflammation.
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INTRODUCTION
Chronic wounds are a common but underrecognized
problem that significantly impacts patients’ quality of life.
The wide range of therapeutic options for these wounds
indicates that the mechanisms responsible for non-healing
wounds are poorly understood. Hyperbaric oxygen therapy
(HBOT) has been used to treat chronic wounds for about 40
years on the assumption that delivery of increased oxygen to
the wound will improve healing. Several randomized,
controlled trials have shown the benefit of HBOT in diabetic
foot ulcer outcome as measured by reduction in the risk
of major amputation (Doctor et al., 1992; Faglia et al.,
1996; Kalani et al., 2002; Abidia et al., 2003; Kessler et al.,
2003), and yet the effect on actual ulcer healing remains
elusive. Treatment of chronic wounds other than diabetic
foot wounds with HBOT has not withstood the rigor of
randomized controlled trials, perhaps because the hetero-
geneity of wounds other than diabetic foot ulcers makes such
trials extremely difficult to perform (Kranke et al., 2004).
Thus, the utility of HBOT for healing chronic wounds remains
a subject of debate. On the other hand, HBOT has been
shown to protect the central nervous system from ischemia or
ischemia–reperfusion injury (Baidin et al., 1997; Rosenthal
et al., 2003). Cited mechanisms for HBO-induced neuropro-
tection include increased oxygen supply (Sunami et al.,
2000), improved cerebral metabolism (Ginsberg, 2003),
reduced inflammation (Thom, 1993), attenuation of apoptosis
(Calvert et al., 2003; Yin et al., 2003), and ischemic tolerance
or ischemic preconditioning (Xiong et al., 2000; Dong et al.,
2002). These beneficial effects suggest that oxygen has
multiple roles when delivered in high concentrations to
an ischemic environment. It is our premise that improved
understanding of the effect of oxygen on ischemic wounds
will lead to more effective, specifically targeted wound
treatments.
Hypoxia-inducible factor-1 (HIF-1) plays a central role in
oxygen homeostasis through a redox-dependent mechanism.
Numerous studies have shown that HIF-1a and its target
genes play an important role in cardiac myocyte death and
brain death caused by hypoxia (Regula et al., 2002; Yussman
et al., 2002; Graham et al., 2004; Li et al., 2005; Ostrowski
et al., 2005; Galvez et al., 2006), and yet the effect of extreme
hyperoxia, which also increases free radicals, is unclear. We
proposed that HBO would regulate HIF-1 through increased
free radical oxygen species and that regulation of HIF-1a-
associated genes would play an important role in the ische-
mic wound healing process. In this study, we examine the
effect of HBO and the free radical scavengerN-acetylcysteine
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RESULTS
Ischemic wound healing is improved by HBO
All of the flaps survived completely without necrosis. As
shown in Figure 1a, ischemic wounds in the HBO-treated rats
were smaller than those in all other groups at each time point.
HBO treatment significantly reduced wound size on day 7
compared with NAC (Po0.05), and on day 10 compared
with NAC and control (Po0.05). The non-ischemic wounds
healed notably faster than ischemic wounds, indicating
that ischemia clearly impairs wound healing and that the
ischemic wound model is reliable and reproducible as
reported previously (Gould et al., 2005). In the non-ischemic
wounds, HBO appears to have a marked effect on wound
size between days 0 and 3. We originally thought that this
was a spurious result; however, HBO has been shown to
enhance epithelial proliferation and migration in the human
skin equivalent model, as reported by Kairuz et al. (2007).
The effect in that in vitromodel is short lived and may explain
why the difference is noted only at day 3 in our model.
Prolonged hypoxia induces transcription factor HIF-1a
HIF-1a expression increased in all groups, peaking on day 7
and decreasing thereafter. As shown in Figure 2a and b, HBO
significantly decreased HIF-1a expression on day 7 (Po0.05).
On the other hand, NAC treatment markedly induced HIF-1a
expression up to day 10, a significant difference from the
other two groups (Po0.05). This pattern of HIF-1a expression
indicates that HBO improves ischemic wound tissue oxygen
supply and protects against hypoxic stress. HIF-1a expression
was much lower in the non-ischemic wound tissue than
that in the ischemic wound tissue (Figure 2c and d). As shown
in Figure 2e, strong HIF-1a staining was detected in the
nuclei of cells, indicating that in ischemic tissue, HIF-1a is
translocated to the nucleus, allowing activation of target
gene transcription. Nuclear staining is less apparent in non-
ischemic wound tissue (Figure 2f).
HBOT decreased vascular endothelial growth factor expression
and inflammation
Vascular endothelial growth factor (VEGF) expression was
induced in the ischemic wound tissue of all groups.
Correlating with HIF-1a, VEGF expression peaked on day 7
and was sustained through day 10 (Figure 3a). Compared to
NAC and control groups, HBO significantly reduced VEGF
protein level at day 7 (Po0.05). The result was confirmed by
immunohistochemistry (Figure 3b–e). Strongly positive VEGF
staining was seen in the epidermis, dermis, and ischemic
wound granulation tissue in the NAC and control groups.
HBO significantly decreased the number of neutrophils
in the wound granulation tissue (Figure 4c). Expression of
the inflammatory marker cyclooxygenase-2 (COX-2) (Seibert
et al., 1995; Nathan, 2002) was also reduced dramatically by
HBOT at day 7 (Figure 4a and b). These data indicate that
HBOT reduces the inflammatory response in ischemic wound
tissue.
p53 and BNip3 protein levels are induced in ischemic wound
tissue and decreased by HBOT
As shown in Figure 5, p53 increased in the ischemic wound
tissue from days 3 to 10. At each time point, HBO decreased
p53 protein expression in the period of wound healing
compared to other groups.
As a member of the Bcl-2 family, BNip3 is likely to be a
direct target gene for HIF-1a (Bruick, 2000; Greijer et al.,
2005). We therefore assessed whether BNip3 was upregu-
lated in a manner consistent with HIF-1a in the ischemic–
hypoxic wound tissue. As shown in Figure 6a and b, 60 kDa
BNip3 was identified after 3 days of wound ischemia. In the
NAC and control groups, BNip3 was strongly expressed
during the entire post-ischemic period. In the HBO treatment
group, BNip3 was highly expressed on day 3 but markedly
reduced by day 7, and was present at low levels on days 10
and 14. Compared to the other two groups, HBO significantly
reduced BNip3 expression on days 7 and 10 (Po0.05). As
shown in Figure 6c and d, the lactate level was higher in the
ischemic wound tissue between days 3 and 14, indicative of
acidosis. Acidosis is known to be required for activation and
stabilization of the BNip3 protein (Graham et al., 2004).
HBOT increased Bcl-2 expression and the Bcl-2/Bax ratio
BNip3 has been shown to form heterodimers with Bcl-2 and
Bcl-xl, which are antiapoptotic Bcl-2 family members. We
next analyzed expression of these two factors. As shown in
Figure 7, HBO dramatically increased Bcl-2 expression at each
time point compared to the other two groups (Po0.05). The
control group had a relatively lower level Bcl-2 expression
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Figure 1. Wound surface area. (a) HBO-treated ischemic wounds healed
faster than all other groups. *Po0.05, HBO versus NAC; #Po0.05,
HBO versus NAC and control. (b) There was no significant difference
between groups in non-ischemic wounds.
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from day 7 to day 14, whereas NAC treatment significantly
inhibited Bcl-2 throughout the time course. Unlike Bcl-2,
Bcl-xl was strongly expressed in all groups and at each time
point. There was no significant difference between the three
groups (data not shown), nor was there a significant difference
in the expression of proapoptotic Bax (data not shown). The
Bcl-2/Bax ratio was markedly increased by HBO treatment at
each time point as shown in Figure 7c.
HBOT decreased active caspase-3 expression and attenuated
apoptosis in ischemic wound tissue
Caspase-3 is a common and reliable apoptotic marker, hence
we next assessed whether HBO decreased its expression.
As shown in Figure 8a and b, HBO significantly decreased
cleaved caspase-3 expression at each time point (Po0.05).
This result was confirmed by immunohistochemistry. As
shown in Figure 9a–f, strongly positive staining for cleaved
caspase-3 was seen in the epidermis and dermis of ischemic
wound tissue in the NAC and control groups. HBO
significantly decreased cleaved caspase-3-positive cell num-
bers in the wound tissue.
TUNEL technique allows the visualization of cell nuclei
containing fragmented DNA, a typical feature of apoptosis.
Positive TUNEL-stained cells were detected in the dermis
and hypodermis of ischemic wound tissue during wound
healing in all groups. As shown in Figure 10a, c, and e, the
TUNEL-positive cell number was significantly decreased by
HBO treatment on days 7 and 14 compared to the other two
groups (Po0.05 and Po0.01, respectively). There was a
significant difference between HBO and NAC groups on
day 10 (Po0.05). The DNA-specific fluorochrome Hoechst
33258 was used to analyze the nuclear morphology after
TUNEL staining. These slides were analyzed for apoptotic
features such as chromatin condensation and nuclear frag-
mentation (von Kobyletzki et al., 2000). As shown in Figure
10b, d, and f, most of the TUNEL-positive cells stained with
Hoechst 33258 revealed an increase in intensity of nuclear
fluorescence by changing their fluorescence characteristics
from dark blue (normal cells) to a light blue/white color,
indicating chromatin condensation.
In addition to TUNEL staining, genomic DNA electro-
phoresis shows only one sample in the HBO-treated group
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Figure 2. HIF-1a expression in ischemic and non-ischemic wounds. (a) Western blot shows the expression of HIF-1a and corresponding b-actin in the
ischemic wound tissue from six animals in each group at each time point. (A representative of three separate blots is shown.) (b) Densitometry analysis shows
that HIF-1a expression increased further in the post-ischemic period, peaked on day 7, and decreased thereafter. HBO significantly decreased HIF-1a expression on
day 7 (*Po0.05, HBO versus NAC and control). NAC treatment markedly induced HIF-1a expression and lasted for 10 days (#Po0.05, NAC versus HBO
and control). (c) HIF-1a and corresponding b-actin bands for non-ischemic wound samples (representative blot). (d) HIF-1a expression increased in the
post-wound period, peaked on day 7, and decreased thereafter. There was no significant difference between HBO and control. HIF-1a expression was markedly
lower than in ischemic wound tissue. (e) Strong HIF-1a staining was detected in the nuclei of fibroblasts (gray arrow), macrophages (black arrow), and endothelial
cells (white arrow) in ischemic wound tissue. (f) Minimal HIF-1a staining was detected in non-ischemic wound tissue with fewer positive nuclei. Bars¼20mm.
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that showed a clear DNA ladder. However, there were four
samples with a clear DNA ladder in the NAC treatment group
and three in the control group (Figure 11). These data clearly
indicate that cell apoptosis is reduced in the HBO treatment
group compared to the other two groups.
HBO effects on cell DNA synthesis
BrdU incorporation into the wound tissue DNA was detected
by the quantitative DNA dot-blotting method. As shown
in Figure 12a and b, a strong BrdU signal was detected in
DNA from six samples in HBO and five samples in the
control group at day 10. Densitometric analysis showed
no significant difference between these groups. However,
NAC significantly decreased BrdU incorporation in ischemic
wound tissue (Po0.05). There was no significant difference
between the three groups in the non-ischemic wound tissue.
These data indicate that HBO has minimal effect on the
induction of cellular DNA synthesis. We have confirmed these
results by immunohistochemistry for proliferating cell nuclear
antigen and by western blotting for phosphoinositide-3 kinase
protein expression (see Supplementary Materials, Figures S1
and S2).
DISCUSSION
The two major findings from this work are that treatment
of ischemic wounds with HBO reduced apoptotic cell
death without a corresponding increase in proliferation, and
that HBO treatment reduced inflammation in the ischemic
wound. To the best of our knowledge, this is the first study to
look at these parameters in ischemic wounds in vivo. The
ischemic flap utilized in this study is designed to create
prolonged ischemia of the tissue in and around the wound.
We have previously shown that the average subcutaneous
tissue oxygen tension (PscO2) at the wound edge is only
30mmHg (based on polarographic measurements) (Gould
et al., 2005). Thus, even the wound margins in this excisional
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Figure 3. VEGF expression in ischemic wound tissue. (a) ELISA result shows
that VEGF expression was induced in the ischemic wound tissue in all
groups. It peaked on day 7, lasted up to day 10, and decreased significantly by
day 14. HBO significantly reduced VEGF protein level on day 7 compared to
NAC and control (*Po0.05, n¼ 6). VEGF staining in the (b, d, and f)
epidermis and (c, e, and g) dermis. Strongly positive VEGF immunostaining
was seen in the epidermis and dermis of ischemic wound tissue in (d, e)
NAC-treated wounds and (f, g) control. VEGF was expressed predominantly in
the endothelial cells (e, white arrow), fibroblast cells (e, gray arrow),
macrophage cells (e, black arrow), and keratinocytes (f, arrow). (b, c) The
number of VEGF-positive cells was decreased by HBO. Bars¼ 20mm.
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Figure 4. COX-2 expression in ischemic wound tissue. (a) Western blot
shows the expression of COX-2 and corresponding b-actin in the wound
tissue from six animals in each group at day 7 (representative blot).
(b) Densitometry analysis shows that HBO significantly decreased
COX-2 expression compared to NAC and control (*Po0.05). COX-2
expression was low in the non-ischemic wound tissue, with no difference
between groups. (c) HBO significantly reduced the number of neutrophils
in ischemic wound tissue at day 7 (*Po0.05).
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Figure 5. p53 expression in ischemic wounds over time. (a) Western blot shows the expression of p53 and corresponding b-actin in the ischemic wound
tissue for all samples (representative blot). (b) Densitometry analysis shows that p53 expression increased in the post-ischemic period, peaked on day 7, and
decreased thereafter. HBO significantly decreased p53 expression on day 7 (*Po0.05). NAC treatment markedly induced p53 expression with the greatest
difference on day 10 (#Po0.01).
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Figure 6. BNip3 expression and lactate levels in ischemic wounds. (a) Western blot shows the expression of BNip3 and corresponding b-actin in the ischemic
wound tissue for all samples (representative blot). (b) Densitometry analysis shows that BNip3 expression increased in the post-ischemic period, peaked
on day 7, and decreased thereafter. HBO significantly decreased BNip3 expression on days 7 and 10 (*Po0.05). (c) L-Lactate was determined
spectrophotometrically at 340 nm using a commercially available kit (Sigma-Aldrich), which follows the production of NADH. The lactate level increased
in ischemic compared to non-ischemic wound tissue at all time points in the control group (*Po0.05). (d) The lactate level was significantly elevated in
ischemic compared to non-ischemic wound tissue on day 7 in all treatment groups. NADH, nicotinamide adenine dinucleotide (*Po0.05).
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wound model are critically hypoxic, mimicking the clinical
scenario of a wound on an ischemic limb. In this study, we
demonstrate that this hypoxic environment results in prolonged
elevation of HIF-1a and associated downstream signals,
including p53 and BNip3, resulting in increased apoptosis.
Therefore, although hypoxia is an essential signal during normal
wound healing, this signaling may be detrimental when the
wound is surrounded by an ischemic environment.
We have shown that HBO increased the rate of wound
healing in the ischemic wounds but not in the non-ischemic
wounds. In conditions of high oxygen, HIF-1a is degraded
by an oxygen-dependent prolyl hydroxylase. We therefore
hypothesized that HIF-1a and subsequent downstream
signaling, including apoptosis, would be reduced by HBO.
This study confirms that hypothesis: HBO decreased HIF-1a
protein expression significantly as well as p53, BNip3, and
VEGF at days 7 and 10. Surprisingly, this effect was not
apparent before day 7. One potential explanation for that is
the intermittent nature of HBO treatment. In the ischemic
rabbit ear model, it has been shown that in the first days of
HBO treatment, the PscO2 of ischemic tissue increases to a
mean of 312±45mmHg and remains elevated for about
4 hours. After 14 days of treatment, although the baseline
tissue PscO2 is not significantly greater, the mean plateau
with treatment is higher (507mmHg), with a more rapid
return to baseline (0.7 hours) (Siddiqui et al., 1997). The
authors suggest that this is due to increased tissue respon-
siveness, possibly due to a relative increase in blood flow in
the ischemic region in direct proportion to the cumulative
number of treatments. In fact, they show that the rapid return
to baseline after HBO treatment occurs by day 7, concurrent
with our data indicating diminished HIF-1a within the wound
bed. This suggests that increased oxygen is reaching the
entire wound bed, resulting in degradation of HIF-1a during
the period of hyperoxia.
In contrast to our results, Sheikh et al. (2000) have
demonstrated increased VEGF at 5 days of HBOT treatment.
This model has a couple of critical differences that may
explain the opposing results. Wound fluid is sampled from a
cylinder instead of the actual tissue. Thus, only secreted
proteins from tissue that is well perfused are sampled.
Shenberger et al. (2007) have demonstrated that hyperoxia
decreases lung VEGF mRNA expression while increasing
VEGF protein within the epithelial lining fluid by stimulating
the release of VEGF from cell-associated stores. Similarly, the
adult retina responds to hyperoxia with reduced expression of
VEGF and pruning of immature vessels (Yamada et al., 1999;
Dor et al., 2001). Thus, we believe that the difference lies in
the fact that we examine tissue VEGF, whereas the model of
Sheikh et al. (2000) looks only at secreted proteins. Because it
is not practical for us to collect wound fluid in this model,
further studies that examine tissue VEGF mRNA might
reconcile the difference. Although not studied in detail in a
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wound model, alternating periods of hyperoxia and hypoxia
in the retina create a very different environment compared to
continuous hyperoxia (Werdich et al., 2004). Furthermore,
work by Hopf et al. (2005) has clearly shown a dose depen-
dence of oxygen therapy. In our model, ischemic wounds
receive once daily HBOT, resulting in marked fluctuations
between hyperoxia and hypoxia, whereas in Sheikh’s model
HBO treatments are twice daily and VEGF sampling is
between the two treatments. Cylinder oxygen measurements
indicate that the oxygen tension may not return to baseline
between treatments, resulting in a condition of near-
continuous hyperoxia.
HIF-1a has been rigorously shown to play a role in
hypoxia-mediated apoptosis via two mechanisms (Carmeliet
et al., 1998). HIF-1a binds to Mdm2, which enhances the
creation of a stable HIF-1a–p53 complex, leading to activa-
tion of p53-mediated transcription in cells (Chen et al., 2003;
Greijer and van der Wall, 2004). p53 can induce and activate
the Bax and Bak proteins, which regulate the release of
cytochrome c from the mitochondria, thereby initiating the
cascade leading to apoptosis mediated by caspase-9 and
caspase-3 (Wei et al., 2001). Second, HIF-1a can increase
expression of BNip3, a proapoptotic member of the Bcl-2
family. The BNip3 promoter contains a functional HIF-1-
responsive element and is potently activated by both hypoxia
and forced expression of HIF-1a (Bruick, 2000). BNip3 has
been shown to form heterodimers with antiapoptotic Bcl-2
family members, such as Bcl-2 and Bcl-xl, and may promote
apoptosis by sequestering these factors (Boyd et al., 1994;
Yasuda et al., 1998).
In this study, we show that both of these proapoptotic
signaling mechanisms occur in the ischemic wound and
contribute to delayed healing. Furthermore, our data support
the concept that oxygen is acting as a signal transducer,
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Figure 10. TUNEL and Hoechst staining of ischemic wound tissue. Apoptotic
cell nuclei stained by TUNEL in the dermis of ischemic wound tissue:
(a) HBO, (c) NAC, and (e) control. TUNEL-positive cell nuclei stained
with Hoechst 33258 revealed brighter fluorescence by changing their
fluorescence characteristics from dark blue (normal cells) to a light blue/white
color due to chromatin condensation (arrow): (b) HBO; (d) NAC; (f) control.
(g) TUNEL-positive cell number was significantly decreased by HBO
treatment on days 7 and 14 (*Po0.05, **Po0.01). There was a significant
difference between HBO and NAC on day 10 (#Po0.05). Bars¼ 20 mm.
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Figure 9. Localization of cleaved caspase-3. Immunohistochemistry shows
strongly positive staining for cleaved caspase-3 in the (c, e) epidermis and
(d, f) dermis of ischemic wound tissue in the NAC and control groups.
Cleaved caspase-3 was expressed predominantly in the endothelial cells
(d, white arrow), fibroblasts (d, gray arrow), and macrophages (d, black arrow),
especially in the dermal and hypodermal layers, and in the keratinocytes
(e, arrow). HBO significantly decreased cleaved caspase-3-positive cell
numbers in the (a) epidermis and (b) dermis of wound tissue. Bars¼ 20mm.
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initiating a series of events that promote wound healing
despite persistent hypoxia in the surrounding tissue. Specifi-
cally, HBO treatment significantly reduced HIF-1a and p53
compared to the ischemic wounds from day 3 to day 10. In
addition, BNip3 was strongly upregulated in ischemic
wounds up to day 10. Concurrently, lactate in the
surrounding ischemic tissue was increased because of
anaerobic glycolysis, resulting in lactic acidosis. The coex-
istence of ischemia–hypoxia and acidosis will activate and
stabilize BNip3 protein expression. Delivery of high levels of
oxygen by HBO reduced BNip3 expression and attenuated
BNip3-mediated apoptosis in the wound bed despite
persistently elevated lactate levels. Thus, HBO increased
the antiapoptotic/proapoptotic protein ratio, resulting in
reduced release of proapoptotic molecules from the mito-
chondria and attenuated apoptosis.
NAC is a relatively nonspecific free radical scavenger
that is virtually non-toxic. Because of the ability to act as a
glutathione precursor, NAC has been shown to reduce and in
some cases prevent oxidant-mediated damage to cell culture
or animals (Gillissen and Nowak, 1998). We anticipated that
NAC would improve ischemic wound healing, hypothesizing
that hypoxia would induce the mitochondria to produce free
radicals in excess of the capacity of the endogenous
antioxidant defense system. If NAC scavenges these excess
free radicals, wound healing should improve. In fact, the
effect of NAC was counter to what we expected. We con-
firmed this finding by using an alternative free radical
scavenger. Phenyl-butyl-nitrone is a nitrone spin trap that
forms stable adducts with carbon- and oxygen-centered
radicals. In data not shown, we have demonstrated when
rats with the ischemic flap were treated with and without
daily phenyl-butyl-nitrone for 7 days wound healing was
even more severely impaired than when rats were treated
with NAC. As expected, phenyl-butyl-nitrone markedly
reduced 3-nitrotyrosine (3-NT), but inducible nitric oxide
synthase was induced above and beyond what was found
in the untreated ischemic wounds. Our hypothesis is that
near-complete removal of free radicals by either phenyl-
butyl-nitrone or NAC is detrimental to wound healing
because there is a shift from apoptosis to necrotic cell
death, resulting in increased inflammation and subsequent
increased oxygen consumption. To clarify this as a mecha-
nism, additional experiments in which inducible nitric oxide
synthase is blocked are planned.
This finding ties in well with the second major result of this
paper; that is, HBO treatment reduces inflammation in the
ischemic wound. As part of the adaptive response to hypoxia,
HIF-1a activates the expression of VEGF. Increased VEGF
expression stimulates endothelial cell proliferation and
migration with subsequent capillary sprouting and branching
to increase the delivery of oxygen and nutrients (Wang and
Semenza, 1993). On the other hand, VEGF has been impli-
cated in a variety of chronic inflammatory skin disorders,
including psoriasis and neoplasms (Dvorak et al., 1995;
Ferrara et al., 2003). In these conditions, VEGF is strongly
expressed by epidermal keratinocytes, leading to increased
microvascular permeability and aberrant angiogenesis
(Detmar et al., 1995; Ferrara et al., 2003). Transgenic over-
expression of VEGF in the skin results in increased density of
tortuous cutaneous blood capillaries, increased numbers of
mast cells, enhanced leukocyte rolling, and adhesion in post-
capillary skin venules, suggesting that chronic overexpression
of VEGF by the epidermis actually induces the cardinal
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Figure 11. DNA fragmentation in ischemic and non-ischemic wounds.
(a) The genomic DNA electrophoresis shows that HBO abolished DNA
fragmentation compared to other groups; only one sample showed a clear
DNA ladder. However, four samples in NAC treatment group and three
samples in the control group had clear DNA ladders (a representative of three
experiments). (b) Few DNA ladders were detected in non-ischemic wound
tissue samples.
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Figure 12. Cell proliferation measured by BrdU uptake in ischemic and
non-ischemic wounds. (a) Strong BrdU signal was detected in DNA from
six animals in HBO and five in the control group at day 10. (b) Densitometric
analysis showed that in ischemic wound tissue, NAC significantly
decreased BrdU incorporation (*Po0.05). There was no significant
difference between the three groups in non-ischemic wound tissue.
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features of chronic skin inflammation (Detmar et al., 1998).
VEGF has also been shown to induce matrix metalloprotei-
nases and nitric oxide production, increasing cell migration,
vascular permeability, and inflammation (Noiri et al., 1997;
Lamoreaux et al., 1998; Murohara et al., 1998). In this study,
epidermal and dermal VEGF expression was induced in all
ischemic wound groups at day 3, with prolonged elevation
in the control and NAC-treated groups for 10 days. We
propose that persistently elevated HIF-1a and VEGF, as seen
in chronic ischemia, are detrimental to wound healing,
resulting in immature vascularity and prolonged inflamma-
tion. In contrast, HBO significantly reduced HIF-1a and
VEGF protein expression by day 7, as well as neutrophil
infiltration and expression of the inflammatory mediator
COX-2. These data provide a molecular mechanism for
improved wound healing with HBO treatment that includes
controlling vascular permeability, decreasing tissue edema,
and reducing inflammatory damage from tissue ischemia.
In conclusion, we have demonstrated that HBO treatment
improves healing of ischemic wounds by simultaneously attenu-
ating apoptosis and inflammation. We believe that modulation of
prolonged overexpression of HIF-1a and its target gene signal
axis plays an important role in this response. Although it is
unlikely that this is the only mechanism for the effect of HBO
(Badr et al., 2001; Dean et al., 2003; Mrsic-Pelcic et al., 2004;
Li et al., 2005; Zhang et al., 2005), this is the first step in
elucidating the factors and biological pathways involved in
HBO-mediated healing. It is our premise that an improved
understanding of these mechanisms will result in improved
clinical approaches to heal these very difficult wounds.
MATERIALS AND METHODS
Antibodies anti-p53, anti-Bcl-2, anti-Bcl-xl, anti-Bax, anti-cleaved
caspase-3, and anti-cyclooxygenase-2 were obtained from Cell
Signaling Technology (Beverly, MA). Anti-HIF-1a and antiproliferat-
ing cell nuclear antigen were obtained from Chemicon International
(Temecula, CA), anti-BNip3 was a gift from Richard K Bruik
(University of Texas Southwestern Medical Center, Dallas, TX), anti-
VEGF was obtained from Biogenex (San Ramon, CA), and anti-b-actin
and anti-BrdU were obtained from Sigma-Aldrich (St Louis, MO).
Ischemic tissue animal model and HBO treatment
All procedures were approved by the institution’s Animal Care
Committee and abided by all requirements of the Animal Welfare
Act. Healthy 8-week-old male Sprague–Dawley rats (Charles River
Laboratory, Wilmington, MA) weighing 250–300 g were utilized to
create an ischemic wound model as described previously (Gould
et al., 2005). The HBO treatment was performed daily after the
operation including the day of killing. The animals did not require
anesthesia and breathed spontaneously during HBO treatment. The
rats were placed into an HBO chamber (model number: 800-45,
maximum working pressure 45psig (2.4 atmospheres absolute); Dixie
Manufacturing Co., Baltimore, MD) for 90minutes for each treatment.
After HBO treatment, the rats were placed back into the cages.
Experimental design
Seventy-two rats divided randomly into three groups underwent
daily treatment: HBO (90minutes, 2.4 atm), NAC (150mgkg1 NAC
injected intraperitoneally), or control (neither HBO nor NAC,
intraperitoneal injection of equivalent volume of saline). On days 3,
7, 10, and 14, six rats from each group were anesthetized and ischemic
and non-ischemic wounds were traced on clear plastic. Wound
surface area was calculated using Sigma Scan Image Software (Jandel
Scientific, Corte Medera, CA). Cardiac perfusion with lactated Ringer’s
solution was performed and the wounds were excised for analysis. The
day 10 group received an intraperitoneal injection of BrdU (50mg per
kg body weight, Sigma-Aldrich) 3hours before killing. Non-ischemic
and ischemic wounds were divided in half, with one part of the wound
preserved in 10% buffered formalin for histologic analysis and the
other three parts snap frozen in liquid nitrogen, stored separately at
80 1C, and subsequently used for analysis of protein and DNA.
VEGF assay
Tissue stored at 80 1C was homogenized by pulverization in liquid
nitrogen and transferred to tissue lysis buffer (10mM Tris-HCl, pH
7.4, 150mM NaCl, 1% Triton X-100) plus Protease Inhibitor Cocktail
(Sigma-Aldrich). Following centrifugation at 14,000 r.p.m. for
20minutes, the supernatant was removed and stored at 70 1C.
VEGF levels were determined using a commercially available ELISA
kit (R&D Systems, Minneapolis, MN), according to the manufac-
turer’s instructions. Protein levels in the tissue homogenates were
determined using a commercially available kit according to the BCA
(bicinchoninic acid) method (Pierce Biotechnology, Rockford, IL).
VEGF levels were expressed as picograms per milligram protein.
Western blot
Tissue homogenates as described above were also used for western
blotting. Equal amount of protein per lane (40 mg) was separated by
4–15% SDS-PAGE (Bio-Rad, Hercules, CA) and transferred to
polyvinylidene difluoride membrane (Bio-Rad). The membrane
was blocked by 10% non-fat powdered milk in Tris-buffered saline
with Tween-20 (TBST) (50mM Tris-HCl, pH 7.5, 150mM NaCl,
0.05% Tween-20). The membrane was incubated with the primary
antibody in 5% non-fat milk in TBST overnight at 4 1C, washed
extensively with TBST, and then incubated with the secondary
antibody for 40minutes at room temperature. Bands were visualized
with enhanced chemiluminescence (Amersham, Arlington Heights,
IL). Relative quantities of protein were determined using a
densitometer (Kodak Digital Science 1D Analysis Software,
Rochester, NY) and presented in comparison with b-actin expression.
Lactate assay
Tissue was homogenized in 3 M HClO4, transferred to tubes in a 8
to 10 1C ice–salt bath, and agitated until mixed. One milliliter
H2O/0.3ml HClO4 was added and the suspension was mixed at
4 1C for 10minutes. Following centrifugation at 11 500 r.p.m. for
10minutes at 4 1C, the supernatant was removed and stored at
70 1C. L-Lactate was determined spectrophotometrically at 340 nm
using a commercially available kit (Sigma-Aldrich).
Immunohistochemistry
The tissue was fixed with 10% formalin, embedded in paraffin, and
sectioned at 5mm thickness. Sections were deparaffinized, rehy-
drated, and washed in distilled water. They were then placed in
95 1C antigen retrieval citrate buffer (Biogenex) in a steamer for
10minutes. Endogenous peroxidases were blocked by incubation
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with peroxide block (Innogenex, San Ramon, CA) and nonspecific
binding was blocked with normal goat serum (Vector Labs,
Burlingame, CA). Sections were incubated overnight with primary
antibody at 4 1C (anti-HIF-1a 1:500, anti-VEGF 1:500, anti-cleaved
caspase-3 1:1,000, and anti-proliferating cell nuclear antigen 1:500).
After washing, biotinylated secondary antibody was applied for
30minutes, followed by streptavidin–horseradish peroxidase com-
plex (Vectastain ABC kit; Vector Labs), DAB solution (DAB kit;
Vector Labs), and counterstaining with hematoxylin. Slides were
dehydrated, mounted, and viewed. Image-Pro Plus V.4.5 Software
(Media Cybernetics, Silver Spring, MD) was used to quantify the
positive staining per high-powered field in each section. Three visual
fields were evaluated and expressed as the average number of
positive cells per high-powered field.
TUNEL and Hoechst 33258 co-staining
TUNEL assay was performed according to the protocol provided
by the manufacturer (In Situ Cell Death Detection kit, POD;
Hoffman La Roche Ltd, Basel, Switzerland). In brief, paraffin-
embedded tissue sections were mounted on silanated slides,
deparaffinized in xylene, and rehydrated and washed in distilled
water. The slides were stripped of protein by digestion with
20 mgml1 proteinase K in 10mM Tris-HCl (pH 7.4) at room
temperature for 15minutes. After washing, labeling was performed
by covering sections with the TUNEL reaction mixture at 37 1C for
60minutes. The sections were washed and then overlaid with
0.2 mmml1 Hoechst 33258 (Sigma-Aldrich) for 1minute at room
temperature for double staining as described previously by von
Kobyletzki et al. (2000). Slides were washed, mounted, and
examined under a fluorescence microscope (Nikon Eclipse E600;
Nikon Instruments Inc., Melville, NY) with immediate photography.
DNA electrophoresis
To isolate genomic DNA from wound tissues, the homogenized
tissue was incubated with DNA isolation buffer (50mM Tris-HCl, pH
8.0, 100mM EDTA, 0.5% SDS) containing 0.5mgml1 proteinase K
at 55 1C overnight. Phenol and phenol–chloroform–isoamyl alcohol
extraction was performed and the DNA in the aqueous phase was
precipitated with 3M sodium acetate. After washing with 70%
ethanol, the DNA samples were dissolved in TE buffer (10mM
Tris-HCl, pH 8.0, 1mM EDTA). The DNA concentration was
measured by spectrophotometry. A 500 ng DNA sample per well
was loaded onto 1.2% agarose gel containing 2 mgml1 ethidium
bromide, and electrophoresis was conducted at 90V for 1 hour
in 1 TBE buffer (90mM Tris-borate, 2mM EDTA). The gel was
visualized under UV light.
DNA dot-blotting for BrdU quantitation
A novel dot-blotting method for BrdU quantitation was performed
as described by Ueda et al. (2005). Briefly, the purified DNA was
incubated with 10 volumes of 0.4 N NaOH for 30minutes at room
temperature and kept on ice to prevent annealing. The DNA solution
was neutralized with an equal volume of 1M Tris-HCl (pH 6.8), and
100 ng in 5ml was dot-blotted onto a nitrocellulose membrane
and fixed by UV cross-linking (Fisher Scientific, Waltham, MA). The
membrane was incubated with BrdU primary antibody (1:2,000) for
1 hour at room temperature. After being washed with TBST, the
membrane was incubated with a secondary antibody, and analyzed
by enhanced chemiluminescence. The intensity of each BrdU signal
was quantified by densitometric analysis using Kodak software.
Statistical analysis
Data are presented as mean±SEM. One-way analysis of variance
with post hoc comparisons using Tukey’s highly significant
difference test was used to determine the statistical significance
between groups using InStat version 3.0 (GraphPad Software,
San Diego, CA). A P-value less than 0.05 was considered significant.
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Figure S1. Strongly positive proliferating cell nuclear antigen signal was seen
in the cell nuclei in the (a, c, and e) epidermis and (b, d, and f) dermis of
ischemic wound tissue in all groups at day 7.
Figure S2.Western blot shows phosphoinositide-3 kinase (PI3K) expression in
ischemic wound tissue at days 7 and 10.
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